Abraham M.A.

Yue J.T.

LaPierre M.P.

Rutter G.A.

Light P.E.

Filippi B.M.

Lam T.K. Hypothalamic glucagon signals through the KATP channels to regulate glucose production. Mol. Metab. 3 : 202-208 View in Article Scopus (19)

PubMed

Crossref

Google Scholar

Ali S.

Ussher J.R.

Baggio L.L.

Kabir M.G.

Charron M.J.

Ilkayeva O.

Newgard C.B.

Drucker D.J. Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction. Mol. Metab. 4 : 132-143 View in Article Scopus (36)

PubMed

Crossref

Google Scholar

Aasum E.

Belke D.D.

Severson D.L.

Riemersma R.A.

Cooper M.

Andreassen M.

Larsen T.S. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator. Am. J. Physiol. Heart Circ. Physiol. 283 : H949-957 View in Article Scopus (134)

PubMed

Crossref

Google Scholar

Aw D.K.

Sinha R.A.

Xie S.Y.

Yen P.M. Differential AMPK phosphorylation by glucagon and metformin regulates insulin signaling in human hepatic cells. Biochem. Biophys. Res. Commun. 447 : 569-573 View in Article Scopus (20)

PubMed

Crossref

Google Scholar

Ayala J.E.

Bracy D.P.

James F.D.

Julien B.M.

Wasserman D.H.

Drucker D.J. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology. 150 : 1155-1164 View in Article Scopus (79)

PubMed

Crossref

Google Scholar

Banting F.G.

Best C.H.

Collip J.B.

Campbell W.R.

Fletcher A.A. Pancreatic extracts in the treatment of Diabetes Mellitus. Can. Med. Assoc. J. 12 : 141-146 View in Article PubMed

Google Scholar

Barouch L.A.

Berkowitz D.E.

Harrison R.W.

O'Donnell C.P.

Hare J.M. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 108 : 754-759 View in Article Scopus (252)

PubMed

Crossref

Google Scholar

Cao J.

Meng S.

Chang E.

Beckwith-Fickas K.

Xiong L.

Cole R.N.

Radovick S.

Wondisford F.E.

He L. Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK). J. Biol. Chem. 289 : 20435-20446 View in Article Scopus (89)

PubMed

Crossref

Google Scholar

Conarello S.L.

Jiang G.

Mu J.

Li Z.

Woods J.

Zycband E.

Ronan J.

Liu F.

Roy R.S.

Zhu L.

et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia. 50 : 142-150 View in Article Scopus (140)

PubMed

Crossref

Google Scholar

Demarco V.G.

Ford D.A.

Henriksen E.J.

Aroor A.R.

Johnson M.S.

Habibi J.

Ma L.

Yang M.

Albert C.J.

Lally J.W.

et al. Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice. Endocrinology. 154 : 159-171 View in Article Scopus (36)

PubMed

Crossref

Google Scholar

Gelling R.W.

Du X.Q.

Dichmann D.S.

Romer J.

Huang H.

Cui L.

Obici S.

Tang B.

Holst J.J.

Fledelius C.

et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. USA. 100 : 1438-1443 View in Article Scopus (359)

PubMed

Crossref

Google Scholar

Gu W.

Yan H.

Winters K.A.

Komorowski R.

Vonderfecht S.

Atangan L.

Sivits G.

Hill D.

Yang J.

Bi V.

et al. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia. J. Pharmacol. Exp. Ther. 331 : 871-881 View in Article Scopus (72)

PubMed

Crossref

Google Scholar

Gu W.

Winters K.A.

Motani A.S.

Komorowski R.

Zhang Y.

Liu Q.

Wu X.

Rulifson I.C.

Sivits Jr., G.

Graham M.

et al. Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor. Am. J. Physiol. Endocrinol. Metab. 299 : E624-E632 View in Article Scopus (36)

PubMed

Crossref

Google Scholar

Guan H.P.

Yang X.

Lu K.

Wang S.P.

Castro-Perez J.M.

Previs S.

Wright M.

Shah V.

Herath K.

Xie D.

et al. Glucagon receptor antagonism induces increased cholesterol absorption. J. Lipid Res. 56 : 2183-2195 View in Article Scopus (37)

PubMed

Crossref

Google Scholar

Haluzik M.

Colombo C.

Gavrilova O.

Chua S.

Wolf N.

Chen M.

Stannard B.

Dietz K.R.

Le Roith D.

Reitman M.L. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology. 145 : 3258-3264 View in Article Scopus (141)

PubMed

Crossref

Google Scholar

He L.

Chang E.

Peng J.

An H.

McMillin S.M.

Radovick S.

Stratakis C.A.

Wondisford F.E. Activation of the cAMP-PKA pathway antagonizes metformin suppression of hepatic glucose production. J. Biol. Chem. 291 : 10562-10570 View in Article Scopus (13)

PubMed

Crossref

Google Scholar

Holland W.L.

Miller R.A.

Wang Z.V.

Sun K.

Barth B.M.

Bui H.H.

Davis K.E.

Bikman B.T.

Halberg N.

Rutkowski J.M.

et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17 : 55-63 View in Article Scopus (529)

PubMed

Crossref

Google Scholar

Jazayeri A.

Doré A.S.

Lamb D.

Krishnamurthy H.

Southall S.M.

Baig A.H.

Bortolato A.

Koglin M.

Robertson N.J.

Errey J.C.

et al. Extra-helical binding site of a glucagon receptor antagonist. Nature. 533 : 274-277 View in Article Scopus (125)

PubMed

Crossref

Google Scholar

Kazda C.M.

Ding Y.

Kelly R.P.

Garhyan P.

Shi C.

Lim C.N.

Fu H.

Watson D.E.

Lewin A.J.

Landschulz W.H.

et al. Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies. Diabetes Care. 39 : 1241-1249 View in Article Scopus (79)

PubMed

Crossref

Google Scholar

Koth C.M.

Murray J.M.

Mukund S.

Madjidi A.

Minn A.

Clarke H.J.

Wong T.

Chiang V.

Luis E.

Estevez A.

et al. Molecular basis for negative regulation of the glucagon receptor. Proc. Natl. Acad. Sci. USA. 109 : 14393-14398 View in Article Scopus (89)

PubMed

Crossref

Google Scholar

Kuroda M.

Honnor R.C.

Cushman S.W.

Londos C.

Simpson I.A. Regulation of insulin-stimulated glucose transport in the isolated rat adipocyte. cAMP-independent effects of lipolytic and antilipolytic agents. J. Biol. Chem. 262 : 245-253 View in Article PubMed

Google Scholar

Kusminski C.M.

Holland W.L.

Sun K.

Park J.

Spurgin S.B.

Lin Y.

Askew G.R.

Simcox J.A.

McClain D.A.

Li C.

Scherer P.E. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat. Med. 18 : 1539-1549 View in Article Scopus (230)

PubMed

Crossref

Google Scholar

Lee Y.

Naseem R.H.

Duplomb L.

Park B.H.

Garry D.J.

Richardson J.A.

Schaffer J.E.

Unger R.H. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc. Natl. Acad. Sci. USA. 101 : 13624-13629 View in Article Scopus (113)

PubMed

Crossref

Google Scholar

Lee Y.

Berglund E.D.

Yu X.

Wang M.Y.

Evans M.R.

Scherer P.E.

Holland W.L.

Charron M.J.

Roth M.G.

Unger R.H. Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc. Natl. Acad. Sci. USA. 111 : 13217-13222 View in Article Scopus (49)

PubMed

Crossref

Google Scholar

Liao Y.

Takashima S.

Maeda N.

Ouchi N.

Komamura K.

Shimomura I.

Hori M.

Matsuzawa Y.

Funahashi T.

Kitakaze M. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc. Res. 67 : 705-713 View in Article Scopus (182)

PubMed

Crossref

Google Scholar

Mori J.

Patel V.B.

Abo Alrob O.

Basu R.

Altamimi T.

Desaulniers J.

Wagg C.S.

Kassiri Z.

Lopaschuk G.D.

Oudit G.Y. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation. Circ Heart Fail. 7 : 327-339 View in Article Scopus (93)

PubMed

Crossref

Google Scholar

Okamoto H.

Kim J.

Aglione J.

Lee J.

Cavino K.

Na E.

Rafique A.

Kim J.H.

Harp J.

Valenzuela D.M.

et al. Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys. Endocrinology. 156 : 2781-2794 View in Article Scopus (38)

PubMed

Crossref

Google Scholar

Park T.S.

Hu Y.

Noh H.L.

Drosatos K.

Okajima K.

Buchanan J.

Tuinei J.

Homma S.

Jiang X.C.

Abel E.D.

Goldberg I.J. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49 : 2101-2112 View in Article Scopus (223)

PubMed

Crossref

Google Scholar

Park T.S.

Rosebury W.

Kindt E.K.

Kowala M.C.

Panek R.L. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice. Pharmacol. Res. 58 : 45-51 View in Article Scopus (68)

PubMed

Crossref

Google Scholar

Pettus J.

Reeds D.

Cavaiola T.S.

Boeder S.

Levin M.

Cava E.

Thai D.

Shi J.

Yan H.

Bautista E.

et al. REMD-477, a human glucagon receptor antibody, reduces daily insulin requirements and improves glycemic control in people with type 1 diabetes. Diabetes. 66 : A100 View in Article PubMed

Google Scholar

Radovits T.

Korkmaz S.

Loganathan S.

Barnucz E.

Bömicke T.

Arif R.

Karck M.

Szabó G. Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol. 297 : H125-H133 View in Article Scopus (70)

PubMed

Crossref

Google Scholar

Wang M.Y.

Yan H.

Shi Z.

Evans M.R.

Yu X.

Lee Y.

Chen S.

Williams A.

Philippe J.

Roth M.G.

Unger R.H. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway. Proc. Natl. Acad. Sci. USA. 112 : 2503-2508 View in Article Scopus (59)

PubMed

Crossref

Google Scholar

Yagyu H.

Chen G.

Yokoyama M.

Hirata K.

Augustus A.

Kako Y.

Seo T.

Hu Y.

Lutz E.P.

Merkel M.

et al. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111 : 419-426 View in Article Scopus (263)

PubMed

Crossref

Google Scholar